| Valproic acid | Approved Investigational | ANLN | 54443 |
downregulated | Valproic Acid results in decreased expression of ANLN mRNA | 7p14.2 | |
| Valproic acid | Approved Investigational | ANO2 | 57101 |
downregulated | Valproic Acid results in decreased expression of ANO2 mRNA | 12p13.31 | |
| Valproic acid | Approved Investigational | ANO3 | 63982 |
upregulated | Valproic Acid results in increased expression of ANO3 mRNA | 11p14.2 | |
| Valproic acid | Approved Investigational | ANO4 | 121601 |
upregulated | Valproic Acid results in increased expression of ANO4 mRNA | 12q23.1 | |
| Valproic acid | Approved Investigational | ANO5 | 203859 |
upregulated | Valproic Acid results in increased expression of ANO5 mRNA | 11p14.3 | |
| Valproic acid | Approved Investigational | ANOS1 | 3730 |
downregulated | Valproic Acid results in decreased expression of ANOS1 mRNA | Xp22.31 | |
| Valproic acid | Approved Investigational | ANOS1 | 3730 |
upregulated | Valproic Acid results in increased expression of ANOS1 mRNA | Xp22.31 | |
| Valproic acid | Approved Investigational | ANP32A-IT1 | 80035 |
downregulated | Valproic Acid results in decreased expression of ANP32A-IT1 mRNA | 15q23 | |
| Valproic acid | Approved Investigational | ANP32B | 10541 |
downregulated | Valproic Acid results in decreased expression of ANP32B mRNA | 9q22.33 | |
| Valproic acid | Approved Investigational | ANTXR1 | 84168 |
upregulated | Valproic Acid results in increased expression of ANTXR1 mRNA | 2p13.3 | |
| Valproic acid | Approved Investigational | ANTXR2 | 118429 |
downregulated | Valproic Acid results in decreased expression of ANTXR2 mRNA | 4q21.21 | |
| Valproic acid | Approved Investigational | ANTXR2 | 118429 |
upregulated | Valproic Acid results in increased expression of ANTXR2 mRNA | 4q21.21 | |
| Valproic acid | Approved Investigational | ANXA1 | 301 |
upregulated | Valproic Acid results in increased expression of ANXA1 mRNA | 9q21.13 | |
| Valproic acid | Approved Investigational | ANXA11 | 311 |
upregulated | Valproic Acid results in increased expression of ANXA11 mRNA | 10q22.3 | |
| Valproic acid | Approved Investigational | ANXA2 | 302 |
upregulated | Valproic Acid results in increased expression of ANXA2 mRNA | 15q22.2 | |
| Valproic acid | Approved Investigational | ANXA2P1 | 303 |
upregulated | Valproic Acid results in increased expression of ANXA2P1 mRNA | 4q31.3 | |
| Valproic acid | Approved Investigational | ANXA2P2 | 304 |
upregulated | Valproic Acid results in increased expression of ANXA2P2 mRNA | 9p13.3 | |
| Valproic acid | Approved Investigational | ANXA2P3 | 305 |
upregulated | Valproic Acid results in increased expression of ANXA2P3 mRNA | 10q21.3 | |
| Valproic acid | Approved Investigational | ANXA3 | 306 |
upregulated | Valproic Acid results in increased expression of ANXA3 mRNA | 4q21.21 | |
| Valproic acid | Approved Investigational | ANXA4 | 307 |
upregulated | Valproic Acid results in increased expression of ANXA4 mRNA | 2p13.3 | |
| Valproic acid | Approved Investigational | ANXA5 | 308 |
upregulated | Valproic Acid results in increased expression of ANXA5 mRNA | 4q27 | |
| Valproic acid | Approved Investigational | ANXA6 | 309 |
upregulated | Valproic Acid results in increased expression of ANXA6 mRNA | 5q33.1 | |
| Valproic acid | Approved Investigational | ANXA7 | 310 |
upregulated | Valproic Acid results in increased expression of ANXA7 mRNA | 10q22.2 | |
| Valproic acid | Approved Investigational | ANXA9 | 8416 |
upregulated | Valproic Acid results in increased expression of ANXA9 mRNA | 1q21.3 | |
| Valproic acid | Approved Investigational | AOAH | 313 |
downregulated | Valproic Acid results in decreased expression of AOAH mRNA | 7p14.2 | |